{
    "code": "02023203",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023203",
    "time": "2021-05-28 05:48:25",
    "許可證字號": "衛署藥輸字第023203號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/06\/18",
    "發證日期": "90\/06\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202320308",
    "中文品名": "使肺泰２５０準納乾粉吸入劑",
    "英文品名": "SERETIDE 250 ACCUHALER INHALATION POWDER",
    "適應症": "STRETIDE適用於可逆性呼吸道阻塞疾病(ROAD)之常規治療，包括適合使用支氣管擴張劑及皮質類固醇組合療法之患有氣喘的兒童與成人。這可能包括：正在使用長效乙型作用劑(β-AGONIST)及吸入型皮質類固醇之有效維持劑量的患者。正在接受吸入型皮質類固醇療法，而仍有症狀之患者。接受支氣管擴張劑之常規治療，而需要吸入型皮質類固醇之患者。SERETIDE適用於嚴重慢性阻塞性肺部疾病(FEV1",
    "劑型": "105粉狀吸入劑",
    "包裝": "50\/250MGC,60,120劑量碟型塑膠殼裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "SALMETEROL XINAFOATE MICRONIZED, FLUTICASONE PROPIONATE MICRONIZED",
    "限制項目": "02輸　入",
    "申請商名稱": "1115901100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": [
        {
            "製造廠名稱": "FFR0183000  GLAXO WELLCOME PRODUCTION",
            "製造廠廠址": "23 RUE LAVOISIER, ZONE INDUSTRIELLE NO.2, 27000 EVREUX, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "1225204000  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216002920",
            "成分名稱": "SALMETEROL XINAFOATE MICRONIZED",
            "含量描述": "72.5",
            "含量": "72.5000000000",
            "單位": "MCG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8406002220",
            "成分名稱": "FLUTICASONE PROPIONATE MICRONIZED",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MCG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "直徑約8.5cm, 高約3cm",
        "特殊劑型": "",
        "顏色": "雙紫色碟型容器",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓凸形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020232030003-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023203&Seq=003&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020232030001-仿單-109-07-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023203&Seq=024&Type=9"
        },
        {
            "title": "02023203_Seretide 250 Accuhaler Inhalation Powder外盒標籤-107-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023203&Seq=004&Type=8"
        }
    ]
}